Kanazawa University, have captured real-time images showing how a key brain enzyme organizes itself to help memory formation.
News-Medical.Net on MSN
Targeting IDO1 for cancer: Novel degraders show promise in preclinical studies
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these ...
Leaf senescence determines the duration of photosynthesis, nutrient remobilization efficiency, and ultimately crop yield and ...
About 130 years ago, American physician William Coley injected a terminally ill cancer patient with a lethal cocktail of ...
Degrader of cancer protein IDO1 prevents cancer immune suppression by cancer and offers promising strategy to support existing immunotherapies ...
Detailed price information for Gain Therapeutics Inc (GANX-Q) from The Globe and Mail including charting and trades.
The breakthrough tackles a longstanding challenge in genetic medicine with the goal of developing a new generation of curative cell and gene ...
Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.
Zacks Small Cap Research on MSN
YDES: YD Biopharma is an integrated biotechnology company that is poised to have a transformational year as it expands business operations
YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and ...
Scientists have discovered that blocking a key cellular enzyme thought to protect against fatty liver disease may instead ...
We know the genes, but not their functions—to resolve this long-standing bottleneck in microbial research, a joint research ...
A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results